Physician profile
Jay Harris Levy
NPI 1851388201
$3,744.03
in general payments reported to CMS, 2019-2025
16 companies · $674 in 2025
The $674 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $138 · 2021: $99.48 · 2022: $1,285 · 2023: $498 · 2024: $479 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,651.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $1,206.59 | 2019-2025 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $685.81 | 2019-2024 | Eylea, Eylea Hd |
| Apellis Pharmaceuticals, INC. | $384.50 | 2022-2025 | Syfovre |
| Notal Vision, INC. | $321.39 | 2022 | |
| Alcon Vision LLC | $289.79 | 2023-2025 | Unity, Constellation |
| Abbvie INC. | $287.57 | 2023-2025 | |
| Horizon Therapeutics Plc | $149.83 | 2022 | |
| Novartis Pharmaceuticals Corporation | $127.11 | 2019 | |
| Allergan, INC. | $112.59 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $45.46 | 2020-2021 | |
| Astellas Pharma US INC | $27.46 | 2025 | Izervay |
| Johnson & Johnson Surgical Vision, INC. | $25.86 | 2020 | |
| Iridex Corporation | $24.75 | 2023 | |
| Aerie Pharmaceuticals, INC. | $20.33 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.26 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $15.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.